The Report Guru

According to research report the global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Opportunities: Increasing adoption of advanced robotics in ASCs Ambulatory surgery centers (ASCs) are freestanding facilities specializing in surgical, diagnostic, and preventive procedures that do not require hospital admission. The cost-effectiveness of ASCs provides significant savings

According to research report the global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the increasing development in the area such as neurodegenerative diseases and cancer. Along with this, launch of several advanced products are contributing towards the growth of the market. On the other hand, need of high initial investments, and dearth of skilled professionals are some factors limiting the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The market for spatial genomics & transcriptomics is highly consolidated, with key players strategizing to capture the market. Prominent players in the market are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic V

According to the report Breast Imaging Market  is projected to reach USD 6.6 billion by 2028 from USD 4.4  billion in 2023, at a CAGR of 8.5% from 2023 to 2028. The rising number of breast cancer cases, increasing number of old-age people, and rising mobile solutions fuel the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Opportunity: Growth potential in emerging countries Developing economies offers high growth opportunities for key players operating in the breast imaging market. Countries such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa has large population base and offers a sustainable market for diagnostic imaging devices. The demand for diagnostic imaging has significantly increased in emerging economies due to the rising prevalence and growing awareness of breast cancer. The Indian government is focusing on providing the insurance scheme under the Ayushman Bharat program. The growth in the e

According to research report the global tangential flow filtration market is set for substantial growth, with a revenue estimation of $1.9 billion in 2023, and a projected expansion to $3.6 billion by 2028, showcasing a notable CAGR of 13.5% during this period. This comprehensive research delves into industry trends, pricing dynamics, patent analysis, key stakeholders, and market behavior. The market's robust growth is attributed to increasing R&D investments in pharma-biotech companies and ongoing technological advancements in filtration technologies. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607 The global tangential flow filtration market is a consolidated market. The market is estimated to grow to USD 3.6 billion by 2028 from USD 1.9 billion in 2023, at a CAGR of 13.5%. TFF market can be attributed to technological advancements in TFF over normal flow filtration, rising R&D spending, growing pharmaceutical & b

The global Infection Surveillance Solutions Market  is projected to reach USD 1,100 million by 2027 from USD 577 million in 2022, at a CAGR of 13.8% during the forecast period. Growth in this market is predominantly driven by the increasing prevalence of hospital-acquired infections and new Medicare policies, including non-payment for hospital-acquired conditions. The rising number of surgeries, the growing geriatric population, the increasing incidence of chronic diseases, and increasing adoption of antimicrobial stewardship programs are the other factors driving the growth of this market. However, data breaches, and lack of skilled analysts are expected to hamper the growth of this market during the forecast period to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517 Opportunities: Emerging Markets The infection surveillance solutions market is expected to experience significant growth opportunities in countries wit

The global  cancer biomarkers market is projected to reach USD 28.2 billion by 2026 from USD 12.4 billion in 2021, at a CAGR of 17.7% during the forecast period. Growth in the cancer biomarkers market is mainly driven by factors such as the increasing use of cancer biomarkers in drug discovery & development and increasing R&D on cancer biomarkers. However, patent protection of cancer biomarkers and limited battery life are the major factors hampering the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 Opportunity: Personalized medicine Personalized medicine identifies the most beneficial treatment path for individual patients. Cancer biomarkers play a very important role in certain aspects of personalized medicine. Consumables used in cancer biomarker testing enable the identification of these diseases. Cancer biomarker diagnostic products are also used as companion diagnostics for several investigational

The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2020, at a CAGR 7.2% from 2021 to 2026. The growth of this market is driven by increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicines Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321 Opportunity: Growing opportunity in emerging markets Emerging countries such as China, Brazil, Mexico, and India present significant opportunities for players in the cell lysis market. The major reasons for this are the increasing prevalence of chronic diseases, improvements in infrastructure facilities for research, and favorable legislation for cell-based research in emerging countries. Due to this, key industry players strengthen their presence in emerging countries like China by establishing new facilities and R&D and innovation centers in the region. Challenge: Survival of small pla

The global restorative dentistry market is projected to reach USD 7.4 billion by 2028 from USD 5.6  billion in 2023, at a CAGR of 5.5%. Growth in this market is due to high incidence of dental caries which results in an subsequent increase of dental procedures. The changing lifestyle and eating habits is expected to play a major role in driving the demand for restorative dental materials Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210042423 Opportunity: Rising disposable incomes in developing countries The increase in the income levels in developing countries such as India, China, and Brazil, with a relatively high decayed, missing, and filled teeth (DMFT) index, are expected to boost restorative dental products. According to a research study conducted by the International Monetary Fund, one of the leading economic communities in the world-China has shown a considerable increase in the per capita national income. The general growth in th

The microbiome sequencing services market is projected to grow from USD 284 million in 2023 to USD 555 million by 2028 at a CAGR of 14.3%. Growth in this market is majorly driven by the increasing demand for metagenomic sequencing, the growing focus on human microbiome therapeutics development, and the high cost of advanced infrastructure for sequencing. However, a dearth of skilled personnel is expected to hinder the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380 The global microbiome sequencing services market is a fragmented market, with Charles River Laboratories (US), Eurofins Scientific (France), and BGI (China) emerging as the top leading players of the global market. Other prominent players/service providers include CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada), BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Techn

The global hyperspectral imaging systems market is projected to reach $34.3 billion by 2028, growing at a CAGR of 15.4% from 2023 to 2028 during the forecast period. Market growth can largely be attributed to factors such as increasing funding and investments in this field and the growing industrial applications of hyperspectral imaging. Emerging markets in developing economies are expected to offer potential growth opportunities for players operating in the market. The hyperspectral imaging systems market is segmented based on product, technology, application, and region. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The global hyperspectral imaging system market is projected to reach USD 34.3  billion by 2028 from USD 16.8 billion in 2023, at a CAGR of 15.4% during the forecast period. Growing funds and related investments and the untapped opportunities in emerging markets are expected to provide growth opportunities for play

The global Pain Management Devices Market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163 Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (

The global Infection Surveillance Solutions Market is projected to reach USD 1,100 million by 2027 from USD 577 million in 2022, at a CAGR of 13.8% during the forecast period. Growth in this market is predominantly driven by the increasing prevalence of hospital-acquired infections and new Medicare policies, including non-payment for hospital-acquired conditions. The rising number of surgeries, the growing geriatric population, the increasing incidence of chronic diseases, and increasing adoption of antimicrobial stewardship programs are the other factors driving the growth of this market. However, data breaches, and lack of skilled analysts are expected to hamper the growth of this market during the forecast period to a certain extent. Download PDF Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517 Opportunities: Emerging Markets The infection surveillance solutions market is expected to experience significant growth opportunities in countries w

The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The key players in this market are Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Surgical Innovations Group plc (UK), Koninklijke

The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2020, at a CAGR 7.2% from 2021 to 2026. The growth of this market is driven by increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicines. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321 The cell lysis market is highly consolidated and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), Agilent Technologies Inc. (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), NZYTech Lda (Portugal), Labfreez Instruments Group Co., Limited (China), G-Biosciences (US), Covaris (US), Claremont BioSolutions LLC (US), Microfluidics International Corporation (US), Parr Instrument Company (

According to research report the  optical imaging market is consolidated at the top, with the 10 leading players accounting for nearly 80% of the market in 2013. Most of these players are based in developed countries across North America and Europe; however, some, such as Canon, Inc. (based in Japan), are situated in the APAC region. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=894 DRIVERS: Increasing prevalence of eye disorders due to the rising geriatric population The growing prevalence of eye disorders, owing to the rising global geriatric population, is one of the key factors driving the growth of the global market. The tear layer loses stability and degrades faster in the elderly, making them more prone to eye disorders. Therefore, the risk of getting severe eye disorders increases significantly with age, particularly after 60 years. Currently, the prevalence rate of glaucoma is four times higher in individuals aged 80 years and abov

According to research report the global ambulatory EHR market is projected to reach USD 7.7 billion by 2027 from an estimated USD 5.7 billion in 2022, at a CAGR of 6.1% during the forecast period. Growth in this market is primarily driven by the growing demand for HCIT solutions, the rising number of outpatient facilities, rising funding-related initiatives by the government. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627 Drivers: Government support for the adoption of EHR solutions The HCIT industry is one of the fastest-growing industries, which benefits largely from government regulations. EHRs are a central component of HCIT wherein ambulatory EHRs are the digital version of outpatient medical history that store data consisting of patient demographics, progress notes, medications, treatment plans, vital signs, past medical history, immunizations, laboratory data, and radiology reports. Ambulatory EHRs facilitate easy exchange

  The global interventional cardiology devices market is on a high growth trajectory, driven by the rising prevalence of cardiovascular diseases and the adoption of minimally invasive procedures. According to MarketsandMarkets, the market is projected to reach $25.5 billion by 2027, expanding at a CAGR of 7.7% from 2022. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548 A key factor propelling market growth is the rapidly aging population worldwide, which leads to a higher burden of coronary artery disease. Interventional cardiology leverages specialized catheter-based devices to diagnose and treat structural heart conditions through small incisions rather than open-heart surgery. This minimally invasive approach allows for faster patient recovery, reduced hospital stays, and lower risk of infection compared to conventional surgery. The most widely used interventional cardiology devices are stents, which are tiny mesh tubes implanted in c

The global Laboratory Information System market is poised for robust growth in the coming years, driven by the rising adoption of automation and digital solutions in healthcare. According to MarketsandMarkets, the LIS market is projected to reach $4.0 billion by 2028, up from $2.4 billion in 2023, reflecting a healthy CAGR of 10.8%.   Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232312738 Several factors are catalyzing the growth of LIS solutions worldwide. The overarching driver is the growing pressure to enhance efficiency, accuracy, and patient safety in healthcare through better data management. Medical laboratories handle an enormous volume of patient samples and test results daily. Streamlining this complex workload is crucial for optimal laboratory performance. LIS provides a centralized platform to seamlessly collect, store, manage, and share laboratory-generated information. LIS enhances laboratory workflow efficiency by elimin

The epigenetics market is expected to grow significantly in the coming years, reaching $4.3 billion by 2028 at a CAGR of 18.3% from 2023-2028. The growth is driven by increased investment in epigenetics research and the rising demand for epigenetic-based therapeutics. However, limited applications in toxicology and quality concerns over antibodies may restrain market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896 The kits and reagents segment, which includes antibodies, ChiP-seq kits, bisulfite conversion kits, and more, is expected to hold the dominant position in the epigenetics market during the forecast period. This is due to the development of advanced, easy-to-use, and affordable epigenetics kits and reagents. North America accounted for the largest share of the epigenetics market in 2022 due to the presence of epigenetic manufacturing companies in the region and favorable government and private initiatives supporting th

The gene editing market is on an upward trajectory, poised to double in value from USD 5.3 billion in 2023 to a staggering USD 10.6 billion by 2028, sporting a remarkable CAGR of 15.0%. Gene editing, also known as genome engineering, has rapidly evolved to become a powerful tool for the targeted alteration of DNA sequences in organisms and cells. In this article, we explore the dynamics and key players driving the growth of the gene editing market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 Unlocking the Potential: Gene Editing Defined Gene editing, often referred to as genome engineering, involves the precise insertion, deletion, or replacement of DNA at specific locations within an organism's or cell's genome. This revolutionary process is predominantly carried out in laboratories using cutting-edge genome-editing tools, such as CRISPR, TALEN, and ZFN. These tools allow scientists to efficiently and accurately modif